Back to 
BALYASNY ASSET MANAGEMENT L.P.
BALYASNY ASSET MANAGEMENT L.P.
ANTX3 quarters
Position history for BALYASNY ASSET MANAGEMENT L.P.'s holdings in AN2 THERAPEUTICS INC
Yes. Balyasny Asset Management holds 556,027 shares of ANTX (AN2 Therapeutics), worth $2.7M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$2.7M
Current Shares
556,027
Total Value Change
+$2.3M
Total Shares Change
+536,742
Quarter-by-Quarter History
Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.